Long-Term Follow-up of Renal Artery Stenting in an Australian Population

References 

1. Conlon PJ, O’Riordan E, Kalra PA. New insights into the epidemiologic and clinical manifestations of atherosclerotic renovascular disease. Am J Kid Dis. 2000;35(4):573–587
2. Buller CE, Nogareda JG, Ramanathan K, Ricci DR, Djurdjev O, Tinckam KJ, et al. The profile of cardiac patients with renal artery stenosis. JACC. 2004;43:1606–1613
3. Albers FJ. Clinical characteristics of atherosclerotic renovascular disease. Am J Kid Dis. 1994;24(4):636–641
4. Carmichael P, Carmichael AR. Atherosclerotic renal artery stenosis: from diagnosis to treatment. Postgrad Med J. 1999;75:527–536
   • MEDLINE
5. Hanovici H, Zinicda N. Experimental renal artery stenosis. Diagnostic significance of arterial haemodynamics. J Cardiovasc Surg. 1962;3:259–262
6. Zierler RE, Bergelin RO, Isaacson JA, Strandness DE. Natural history of atherosclerotic renal artery stenosis: a prospective study with duplex ultrasonography. J Vasc Surg. 1994;19(2):250–257discussion 257–8
   • Abstract
   • Full Text
   • CrossRef
7. Davidson RA, Barri Y, Wilcox CS. Predictors of cure of hypertension in fibromuscular renovascular disease. Am J Kid Dis. 1996;28:334–338
8. Rimmer JM, Gennari FJ. Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med. 1993;118:712–719
   • MEDLINE
9. Harden PN, MacLeod MJ, Rodger RSC, Baxter GM, Connell JMC, Dominicza KAF, et al. Effect of renal artery stenting on progression of renovascular renal failure. Lancet. 1997;349:1133–1136
   • Abstract
   • Full Text
   • Full-Text PDF (40 KB)
   • CrossRef
10. Plouin PF, Chatellier G, Darne B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. The EMMA-study group. Hypertension. 1998;31:823–829
    • MEDLINE
11. Rees CR, Palmaz JC, Becker GJ, Ehrman KO, Richter GM, Noelge G, et al. Palmaz stent in atherosclerotic stenoses involving the ostia of renal arteries: preliminary report of a multicenter study. Radiology. 1991;181:507–514
    • MEDLINE
12. Pattison JM, Reidy JF, Rafferty MJ, Ogg CS, Cameron JS, Sacks SH, et al. Percutaneous transluminal angioplasty in patients with renal failure. Q J Med. 1992;85:883–888
    • MEDLINE
13. Pattynama PMT, Becker GJ, Brown J, Zemel G, Benenati JF, Katzen BT. Percutaneous angioplasty for atherosclerotic renal artery disease: effect on renal function in azotemic patients. Cardiovasc Intervent Radiol. 1994;17:143–146
    • MEDLINE
14. Geroulakos G, Wright JG, Tober C, Anderson L, Smead WL. Use of splenic and hepatic artery for renal revascularzation in patients with atherosclerotic renal artery disease. Ann Vasc Surg. 1997;11:85–89
    • Abstract
    • Full-Text PDF (437 KB)
    • CrossRef
15. Isles CG, Robertson S, Hill D. Management of renovascular disease: a review of renal artery stenting in ten studies. Q J Med. 1999;92:159–167
16. Beutler JJ, Van Ampting JM, Van De Ven PJ, Koomans HA, Beek FJ, Woittiez AJ, et al. Long-term effects of arterial stenting on kidney function for patients with ostial atherosclerotic renal artery stenosis and renal insufficiency. J Am Soc Neph. 2001;12(7):1475–1481
17. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–470
    • MEDLINE
18. Mathew TH Australasian Creatinine Consensus Working Group. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statement. MJA. 2005;183(3):138–141